Anti-CD47 Antibody Enhances the Efficacy of Chemotherapy in Patients with Gastric Cancer Liver Metastasis

Patients with gastric cancer liver metastasis (GCLM) are often treated with palliative care, and they show a poor prognosis. In gastric cancer, high CD47 expression has been shown to indicate a poor prognosis. CD47, expressed on the cell surface, prevents the cells from being phagocytosed by macroph...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhaorui, Chen, Huiying, Ta, Na, Shi, Zheng, Zhan, Lu, Han, Ting, Zhang, Jinghui, Chang, Xusheng, Yin, Kai, Nie, Mingming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969583/
https://www.ncbi.nlm.nih.gov/pubmed/36860925
http://dx.doi.org/10.7150/jca.80725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969583/
https://www.ncbi.nlm.nih.gov/pubmed/36860925
http://dx.doi.org/10.7150/jca.80725

Ejemplares similares